MedTrace Logo

Allergy Delabeling in Antibiotic Stewardship - Evaluations

NCT06967467 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2025-12-18

No results posted yet for this study

Summary

The goal of this RENEW-EVAL project is to understand the potential barriers to implementation of the RENEW intervention into the routine clinical care of patients with a hematological malignancy.

Conditions

  • Beta Lactam Allergy in Patients With a Hematologic Malignancy

Interventions

BEHAVIORAL

Semi-structured interview

Interviews designed to obtain information about patient reasons for enrolling or declining participation in the RENEW Intervention

BEHAVIORAL

Survey

Survey which will incorporate a series of closed-ended questions eliciting attitudes about the feasibility and acceptability of the intervention, allergy delabeling and future BL antibiotic use

BEHAVIORAL

Ethnographic observation

Observations designed to identify communication and contextual barriers to the implementation of RENEW

BEHAVIORAL

Survey

Survey instruments will measure knowledge,attitudes, and practices surrounding allergy delabeling and antibiotic stewardship in patients with HM and perceptions of the feasibility and acceptability of the RENEW intervention

BEHAVIORAL

Semi-structured interview

Interviews designed to obtain information from clinicians about their perception of the implementation of the RENEW intervention

Sponsors & Collaborators

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-12-01
Primary Completion
2028-09-30
Completion
2029-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06967467 on ClinicalTrials.gov